Current and Future Approaches to Immunotherapy

The History of Cell and Gene Therapy

Immunotherapies Used to Treat Cancer

Frequently Asked Questions About Cell and Gene Therapies

The Technology Behind Bone Marrow Cellular Processing: The PXP® System

Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing

For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.

Clinical BioBanking

With over 20 years of providing cord blood to banks hospitals, researchers and stem clinicians with systems designed to handle stem cells with the highest level of precision, safety, and confidence.

Learn More >

Point-of-Care Solutions

We develop products to obtain bone marrow concentrates easily, consistently, and reliably from bone marrow aspirates at the point-of-care with minimal red blood cell contamination.

Learn More >

Cellular Processing

The first step in the process is often the most important. That's why we have created closed-system novel and innovative technologies aimed at advancing cell therapies to the clinic.

Learn More >

Products for Cellular Processing and Storage

We offer closed automated solutions for manual steps in the cell manufacturing process. Our flexible automated modules provide performance gains in purifying mononuclear cells, washing contaminants from cell fractions, cell selection, and storage while significantly shortening processing times.

X-LAB® System

Rapid isolation of mononuclear cells in a closed system without the need of additional media or manual transfer steps makes the X-LAB System one of a kind. The X-LAB System can be customized to accommodate a range of blood products, input volumes and programmed to provide a specific final product without the need of highly skilled personnel provides great flexibility without compromising MNC recovery.

BioArchive® System

The BioArchive® System is the world’s leading system for preserving and protecting high value cells. It uses proven, computer-controlled technology and tracking software to provide the best protection for today’s valuable samples to meet tomorrow’s cell therapy needs. Fully automated, closed-system sample handling with robotic storage and retrieval ensures consistent temperature control and traceability.

PXP-1000™ System

Efficient processing and separation of cord blood through centrifugation in a fully automated system, the PXP-1000 System is designed to obtain the highest concentration of valuable stem cells and ensuring that they retain their viabilities. The PXP-1000 System accomplishes those tasks in a consistent final volume while reducing more contaminating red blood cells than other systems on the market, making a purer product.

3D Bag Set

The 3D Bag Set is uniquely designed to facilitate the transfer of buffy coat for storage and allows for addition of cryoprotectant in a closed sterile manner. The ease of use, traceability, durability, and safety that the 3D bag Set offers shall allow for long-term storage of the precious cells.

Recent News

Press Releases

ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

May 15, 2023

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., May 15, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2023 … Continued

Press Releases

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

May 10, 2023

Conference Call to be Held on May 15, 2023 RANCHO CORDOVA, Calif., May 10, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2023 … Continued

Press Releases

ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update

March 30, 2023

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., March 30, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the year ended December 31, 2022 and … Continued

Press Releases

ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update

March 28, 2023

Conference Call to be Held on March 30, 2023 RANCHO CORDOVA, Calif., March 28, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will release its financial results for the year ended December 31, 2022 and provide a corporate strategic update … Continued

Press Releases

THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

March 20, 2023

RANCHO CORDOVA, CA — March 20, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the closing of its previously announced purchase and sale of 1,071,429 shares of its common stock (or common stock equivalents) and warrants to … Continued

Press Releases

THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

March 16, 2023

RANCHO CORDOVA, CA — March 16, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has entered into definitive agreements for the purchase and sale of 1,071,429 shares of its common stock (or common stock equivalents) … Continued

Current and Future Approaches to Immunotherapy

The History of Cell and Gene Therapy

Immunotherapies Used to Treat Cancer

Frequently Asked Questions About Cell and Gene Therapies

The Technology Behind Bone Marrow Cellular Processing: The PXP® System

Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing

Products for Cellular Processing and Storage

X-LAB® System

BioArchive® System

PXP-1000™ System

3D Bag Set

Recent News

Click below and be the first to hear about the latest news, breakthroughs, and products with the ThermoGenesis newsletter delivered directly to your inbox.